BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8093650)

  • 1. Strain variation in Epstein-Barr virus immediate early genes.
    Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
    Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells.
    Cochet C; Martel-Renoir D; Grunewald V; Bosq J; Cochet G; Schwaab G; Bernaudin JF; Joab I
    Virology; 1993 Nov; 197(1):358-65. PubMed ID: 8212572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
    Evans TJ; Jacquemin MG; Farrell PJ
    Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
    Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
    Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic cycle gene regulation of Epstein-Barr virus.
    Amon W; Binné UK; Bryant H; Jenkins PJ; Karstegl CE; Farrell PJ
    J Virol; 2004 Dec; 78(24):13460-9. PubMed ID: 15564457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
    Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
    Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus.
    Chang PJ; Liu ST
    J Virol; 2001 Feb; 75(3):1142-51. PubMed ID: 11152487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
    Jung YJ; Choi H; Kim H; Lee SK
    J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies.
    Martel-Renoir D; Grunewald V; Touitou R; Schwaab G; Joab I
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1401-8. PubMed ID: 7782768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
    Speck SH; Chatila T; Flemington E
    Trends Microbiol; 1997 Oct; 5(10):399-405. PubMed ID: 9351176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the epstein-barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1.
    Segouffin-Cariou C; Farjot G; Sergeant A; Gruffat H
    J Gen Virol; 2000 Jul; 81(Pt 7):1791-9. PubMed ID: 10859385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concatenated form of Epstein-Barr viral DNA in lymphoblastoid cell lines induced by transfection with BZLF1.
    Cho MS; Tran VM
    Virology; 1993 Jun; 194(2):838-42. PubMed ID: 8389085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on tissue distribution and expression of Epstein-Barr virus using polymerase chain reaction].
    Oikawa O
    Hokkaido Igaku Zasshi; 1995 Sep; 70(5):729-42. PubMed ID: 8543279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.